PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer.
Yearley, Jennifer H
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2017 - 3158-3167 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-16-1761 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Carcinoma, Squamous Cell--drug therapy
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Head and Neck Neoplasms--drug therapy
Humans
Immunotherapy
Male
Middle Aged
Programmed Cell Death 1 Ligand 2 Protein--antagonists & inhibitors
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Squamous Cell Carcinoma of Head and Neck
PD-L2 Expression in Human Tumors: Relevance to Anti-PD-1 Therapy in Cancer. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Jun 2017 - 3158-3167 p. digital
Publication Type: Journal Article
1557-3265
10.1158/1078-0432.CCR-16-1761 doi
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Humanized--administration & dosage
Carcinoma, Squamous Cell--drug therapy
Disease-Free Survival
Female
Gene Expression Regulation, Neoplastic
Head and Neck Neoplasms--drug therapy
Humans
Immunotherapy
Male
Middle Aged
Programmed Cell Death 1 Ligand 2 Protein--antagonists & inhibitors
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Squamous Cell Carcinoma of Head and Neck